Thermo Fisher Scientific Reports Third Quarter 2019 Results

Go back to Thermo Fisher Scientific Reports Third Quarter 2019 Results

Thermo Fisher Scientific (TMO) PT Raised to $331 at Needham & Company

October 24, 2019 6:57 AM EDT

Needham & Company analyst Stephen Unger raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $331.00 (from $321.00) while maintaining a Buy rating.

The analyst commented, "We are updating our financial model for TMO following yesterday's release of 3Q19 results. We have raised our 2019 EPS estimate... More

Thermo Fisher Scientific (TMO) Tops Q3 EPS by 7c, Revenues Beat; Raises FY19 EPS/Revenue Guidance

October 23, 2019 6:02 AM EDT

Thermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $2.94, $0.07 better than the analyst estimate of $2.87. Revenue for the quarter came in at $6.27 billion versus the consensus estimate of $6.18 billion.

Third Quarter 2019 Highlights

Third quarter revenue increased 6% to $6.27 billion.Third quarter GAAP diluted earnings per share (EPS) increased 7% to $1.88.Third quarter adjusted EPS increased 12% to $2.94.Launched innovative new products for clinical, life sciences and bioproduction applications, highlighted by the FDA-cleared Thermo Scientific TSQ Altis and Quantis MD mass spectrometers and the Vanquish MD HPLC for clinical diagnostic laboratories, a new... More